Phase IV, Rater-blinded, Randomized Study, Comparing the Effects of 250 mg of Betaseron With 20 mg of Copaxone in Patients With the Relapsing-remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-dose Gadolinium
ClinicalTrials.gov, 6 May 2010
Accessed on 21 Mar 2012 from http://clinicaltrials.gov/show/NCT00176592.
